LIU; Qihong

Patent Applications and Registrations

Patent applications and USPTO patent grants for LIU; Qihong.The latest application filed is for "substituted pyrrolo [2, 3-b] pyridine and pyrazolo [3,4-b] pyridine derivatives as protein kinase inhibitors".

Company Profile

6.10.14

LIU; Qihong - Chongqing CN
LIU; Qihong - Nan'an District Chongqing
Liu; Qihong - Xi An CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
SUBSTITUTED PYRROLO [2, 3-b] PYRIDINE AND PYRAZOLO [3,4-b] PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS App 20220235049 - TAN; Haohan ; et al.	2022-07-28
Substituted Imidazo[1,2-a]pyridine And [1,2,4]triazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors App 20220041588 - HE; Chengxi ; et al.	2022-02-10
Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide compounds as inhibitors of indoleamine 2,3-dioxygenase Grant 11,168,078 - Chen , et al. November 9, 2	2021-11-09
Macrocyclic Compounds As Trk Kinases Inhibitors App 20210139506 - ZHANG; Huajie ; et al.	2021-05-13
Sulfoximine, Sulfonimidamide, Sulfondiimine And Diimidosulfonamide Compounds As Inhibitors Of Indoleamine 2,3-dioxygenase App 20210070742 - CHEN; Zhifang ; et al.	2021-03-11
SUBSTITUTED (2-AZABICYCLO[3.1.0]HEXAN-2-YL)PYRAZOLO[1,5-a]PYRIMIDINE AND IMIDAZO[1,2-b]PYRIDAZINE COMPOUNDS AS TRK KINASES INHIBITORS App 20210024528 - LIU; Hongbin ; et al.	2021-01-28
Indolizine derivatives, composition and methods of use Grant 10,894,038 - Li , et al. January 19, 2	2021-01-19
Indolizine Derivatives, Composition And Methods Of Use App 20200113876 - LI; Tonshuang ; et al.	2020-04-16
Certain protein kinase inhibitor Grant 10,450,316 - Zhao , et al. Oc	2019-10-22
Certain protein kinase inhibitors Grant 10,328,060 - Zhao , et al.	2019-06-25
Certain Protein Kinase Inhibitor App 20180291027 - ZHAO; Xingdong ; et al.	2018-10-11
Certain protein kinase inhibitors Grant 10,087,195 - Wang , et al. October 2, 2	2018-10-02
Certain protein kinase inhibitors Grant 10,022,374 - Wang , et al. July 17, 2	2018-07-17
Certain Protein Kinase Inhibitors App 20180036293 - ZHAO; Xingdong ; et al.	2018-02-08
Certain Protein Kinase Inhibitors App 20170267696 - Wang; Weibo ; et al.	2017-09-21
Certain Protein Kinase Inhibitors App 20170105994 - Wang; Weibo ; et al.	2017-04-20
Certain protein kinase inhibitors Grant 9,556,171 - Wang , et al. January 31, 2	2017-01-31
Certain Protein Kinase Inhibitors App 20160083376 - WANG; Weibo ; et al.	2016-03-24
System and method for Ec/Io access screening in a CDMA network Grant 8,687,494 - Lauderdale, II , et al. April 1, 2	2014-04-01
System and Method for Ec/Io Access Screeening in a CDMA Network App 20130170365 - Lauderdale, II; Robert P. ; et al.	2013-07-04
System and method for Ec/Io access screening in a CDMA network Grant 8,159,951 - Lauderdale, II , et al. April 17, 2	2012-04-17
SYSTEM AND METHOD FOR Ec/Io ACCESS SCREENING IN A CDMA NETWORK App 20080151838 - Lauderdale; Robert P. ; et al.	2008-06-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.